Gilead Sciences
Judy Barretto

Senior Director at Gilead Sciences

  United Kingdom

About me

Senior Director in Patient Safety. 20+ years' experience in industry working in multiple companies. Experienced in end to end signal and risk management for the whole product life-cycle.

Schedule

My Session

Panel Discussion: Beyond Compliance: Building a Proactive Drug Safety Culture

How leading organisations are embedding pharmacovigilance into decision-making, culture, and strategy - moving from reactive compliance to proactive patient safety.

  • How can pharmacovigilance move from a compliance function to a strategic driver of patient safety?
  • What does true cross-functional ownership of drug safety look like in practice?
  • Are current KPIs driving the right behaviours or just ticking boxes?
  • How can leadership create accountability for proactive safety decisions?

Quality Assurance
Patient Safety
Global Pharmacovigilance

Michael Ramcharan

Managing Director at Reumat Consulting

Ivana Hezoucky

Regional Patient Safety Manager at Boehringer Ingelheim

Judy Barretto

Senior Director at Gilead Sciences

Sandra Reda

Senior Pharmacovigilance Specialist at Newbridge Pharmaceuticals

Brian Edwards

Managing Director at Husoteria Ltd